	Development and Validation of a Prognostic Model for Lung Cancer Based on Machine Learning and Immune Microenvironment Analysis. J Cell Mol Med Zhang X, Liu F. PMID: 41319095 [PubMed - indexed for MEDLINE]
	Advancing small cell lung cancer metastasis research: innovations in preclinical mouse models. Cancer Metastasis Rev Zhao Q, Hu L, Ji H. PMID: 41318700 [PubMed - indexed for MEDLINE]
	Prognostic Factors in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors. Anticancer Res Takahara Y, Abe R, Nagae S, Tanaka T, Ishige Y, Shionoya I, Yamamura K, Nojiri M, Iguchi M. PMID: 41318160 [PubMed - indexed for MEDLINE]
	Impact of Emphysema Severity on Clinicopathological and Molecular Features in Non-small Cell Lung Cancer. Anticancer Res Yasuura Y, Woo T, Tanaka S, Masuda H, Kameda Y, Inafuku K, Saito A. PMID: 41318138 [PubMed - indexed for MEDLINE]
	Pulmonary Emphysema Assessed by the Goddard Score Predicts Outcomes After Hepatic Resection for Colorectal Liver Metastases. Anticancer Res Furukawa K, Haruki K, Shirai Y, Onda S, Tsunematsu M, Matsumoto M, Uwagawa T, Taniai T, Yanagaki M, Ikegami T. PMID: 41318131 [PubMed - indexed for MEDLINE]
	Impact of Baseline Body Mass Index on Immunotherapy Outcomes in Patients With Non-small-cell Lung Cancer. Anticancer Res Krej, , Opálka P, Krej, , Svato, Pála M, Tesa, Pauk N. PMID: 41318117 [PubMed - indexed for MEDLINE]
	Good Quality 66.7% 5-year Overall Survival in Terminal Lung Cancer Patients Treated With Mifepristone. Anticancer Res Check JH, Check DL, Wilson C. PMID: 41318113 [PubMed - indexed for MEDLINE]
	Prediction of lung metastasis in breast cancer patients using machine learning classifiers. J Mol Diagn Nguyen TD, Nguyen Thi QM, Van Nguyen T, Bui TP, Nguyen Thi KN, Nguyen MN. PMID: 41318062 [PubMed - as supplied by publisher]
	Third-Generation EGFR-TKIs Combined With Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Real-World Study. Cancer Sci Jiang Y, Liang Q, Zhu Y, Liang X, Huang R, Zhou W, Zhang C, Li J, Xu J, Guo R. PMID: 41316804 [PubMed - as supplied by publisher]
	MiR-4701-3p predicts prognosis of non-small cell lung cancer and regulates cell biological behaviors. Hereditas Hao Z, Sun Y, Xu G, Cao J, Pan Y. PMID: 41316500 [PubMed - as supplied by publisher]
	Neural regulation of lung cancer: from mechanisms to clinical implications. Eur J Med Res Xu L, Sun X, Yao Y, Fang H. PMID: 41316431 [PubMed - indexed for MEDLINE]
	Prophylactic cranial irradiation together with molecular subtyping in surgically resected small-cell lung cancer: a inverse-probability-of-treatment weighted cohort study. Respir Res Li R, Xiang Y, Yang L, Dong J, Wang W, Tang F, Bi N. PMID: 41316182 [PubMed - in process]
	Leveraging large language models to extract smoking history from clinical notes for lung cancer surveillance. NPJ Digit Med Luo I, Graber-Naidich A, Zhang M, Kaushik R, Nieda GM, Chen T, Gu B, Choi E, Ding VY, Gunturkun F, Satoyoshi M, Bhat A, Lee TY, Su CC, Ellis-Caleo TJ, Henry AS, Desai M, Backhus LM, Lui NS, Leung A, Neal JW, Kurian AW, Langlotz CP, Wakelee HA, Liang SY, Khan A, Han SS. PMID: 41315854 [PubMed]
	Cost-effectiveness of chest radiography using artificial intelligence for lung cancer screening in South Korea. Sci Rep Kim K, Kim JH, Shin J, Kim MS, Park SH, Chang JH, Han CH, Oh SN. PMID: 41315843 [PubMed - as supplied by publisher]
	Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases. J Immunother Cancer Li YS, Lai W, Yin K, Tu HY, Li L, Lin SH, Li P, Zhou DX, Guo WB, Yang JJ, Zhou Q, Zhong WZ, Zhang XC, Jiang BY, Wang Z, Yang XN, Wang BC, Pan Y, Chen HJ, Xu CR, Zeng L, Chen ZH, Yan HH, Sun H, Dong ZY, Liu SM, Li Y, Luo OJ, Zheng MM, Wu YL. PMID: 41314983 [PubMed - indexed for MEDLINE]
	Categorizing immunotherapy resistance mechanisms in non-small cell lung cancer: how can we perform better? J Immunother Cancer van der Geest D, van Vliet A, Peeper DS, Haanen JBAG, Smit EF, Theelen WSME. PMID: 41314975 [PubMed - indexed for MEDLINE]
	Long-term outcomes of concurrent chemo-proton therapy for unresectable stage III non-small cell lung cancer: a Japanese national registry study. Radiother Oncol Iwata H, Murakami M, Maruo K, Nakamura M, Waki T, Nakamura M, Taguchi H, Inoue K, Araya M, Tatebe H, Satouchi M, Shimizu K, Hashimoto T, Harada H. PMID: 41314394 [PubMed - as supplied by publisher]
	Correlation between F-18 FDG PET/CT-derived metabolic parameters and PD-L1 expression in non-small cell lung cancer patients. Rev Esp Med Nucl Imagen Mol (Engl Ed) Kesim S, Ozulker F, Gul Gecmen G, Turan N. PMID: 41314286 [PubMed - as supplied by publisher]
	Radiotherapy for primary lung cancer: 2025 update. Cancer Radiother Khalifa J, El Houat Y, Thureau S, Darréon J, Antoni D, Blais E, Le Péchoux C, Lerouge D, Levy A, Lucia F, Marguerit A, Martin É, Pichon B, Pourel N, Giraud P, Riet FG. PMID: 41314143 [PubMed - as supplied by publisher]
	Letter to the Editor: "Prognostic Implications of Lymph Node Status in Non-Small-Cell Lung Cancer Patients Before and After Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Study". Clin Lung Cancer Aphale P, Dokania S, Shekhar H. PMID: 41314018 [PubMed - as supplied by publisher]

Articles 1 - 20 / 154482

Page 1 of 7725



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy